600 results on '"Calaminus, Gabriele"'
Search Results
152. Quality of survival in SIOPE brain tumour clinical trials for children aged less than 5 years : Development of a clinical trial protocol
153. Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours
154. Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy
155. The Postoperative Quality of Life in Children and Adolescents with Craniopharyngioma
156. Chromosomal gains of 12p and 1q are not associated with inferior outcome of pediatric and adolescent germ cell tumors
157. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma
158. OR16-3 Posterior Hypothalamus-Sparing Surgery Improves Outcome after Childhood Craniopharyngioma: Results of the Prospective Multinational Trial Kraniopharyngeom 2007
159. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
160. Health status, health-related quality of life, and socioeconomic outcome in childhood brain tumor survivors: a German cohort study
161. Langzeitbeobachtung ehemaliger krebskranker Kinder und Jugendlicher
162. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
163. Quality of survival in SIOPE brain tumour clinical trials for children aged less than 5 years: Development of a clinical trial protocol
164. DNA methylation-based classification of central nervous system tumours
165. PanCareLIFE:The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
166. Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)
167. Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours.
168. GERM-08. EARLIER RECOGNITION OF SYMPTOMS AND DIAGNOSIS MAY REDUCE TREATMENT AND LATE EFFECT BURDEN IN CHILDREN, TEENAGERS AND YOUNG ADULTS WITH INTRACRANIAL GERM CELL TUMOURS
169. GERM-12. PITUITARY FAILURES IN CNS MIXED MALIGNANT GERM CELL TUMORS (MMGCTs). EXPERIENCE GENERATED IN SIOP CNS GCT 96
170. QOL-36. QUALITY OF SURVIVAL IN SIOPE BRAIN TUMOUR CLINICAL TRIALS FOR CHILDREN AGED LESS THAN 5 YEARS: DEVELOPMENT OF A CLINICAL TRIAL PROTOCOL
171. CRAN-01. QUALITY OF LIFE AND GROWTH AFTER CHILDHOOD CRANIOPHARYNGIOMA: RESULTS OF THE MULTINATIONAL TRIAL KRANIOPHARYNGEOM 2007
172. GERM-13. PITUITARY FAILURES IN CNS GERMINOMA. EXPERIENCE GENERATED IN SIOP CNS GCT 96
173. Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms
174. TMIC-47. IMMUNOBIOLOGICAL CHARACTERIZATION OF CNS GERMINOMAS – EVIDENCE FOR INFLAMMATORY AND SUPPRESSIVE IMMUNOLOGICAL MECHANISMS
175. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
176. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOSan open-label, international, randomised controlled trial-1): an open-label, international, randomised controlled trial
177. Questionnaire-based reports of Quality of Survival and direct assessments of cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial
178. Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines
179. Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial
180. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy
181. Clinical and Radiologic Outcomes in Adults and Children Treated with Pencil-Beam Scanning Proton Therapy for Low-Grade Glioma
182. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
183. Late Effects and Long-Term Follow-Up after Cancer in Childhood
184. Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe : Entwicklung kurativer Therapien für Ewing-Sarkome durch interdisziplinäre Kooperationen in Europa
185. The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma: Results of a Prospective Multicenter Study.
186. Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology
187. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
188. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer.
189. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
190. CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways
191. Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy
192. GC-06MANAGEMENT FOR RELAPSED INTRACRANIAL MALIGNANT GERM CELL TUMOURS
193. QOS-17QUESTIONNAIRE-BASED REPORTS OF QUALITY OF SURVIVAL (QOS) AND DIRECT ASSESSMENTS OF COGNITIVE PERFORMANCE IN CHILDREN TREATED FOR MEDULLOBLASTOMA IN THE PNET 4 RANDOMIZED CONTROLLED TRIAL
194. CR-09QUALITY-OF-LIFE AFTER PENCIL BEAM SCANNING PROTON THERAPY FOR PEDIATRIC CRANIOPHARYNGIOMA PATIENTS TREATED AT PAUL SCHERRER INSTITUTE
195. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
196. Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy
197. Die Leitsymptome im Überblick
198. Evaluation of an anthroposophic supportive treatment intervention (ASTI) in children with malignant diseases during intensive chemotherapy
199. Strategies to improve the quality of survival for childhood brain tumour survivors
200. Quality of Life (QoL) in children and adolescents with paediatric malignancies under anthroposophic supportive treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.